Aminex Therapeutics

Aminex Therapeutics, Inc. was founded in 2009 as a drug development company focused on advancing a new cancer immunotherapy. The company was among the first to recognize that polyamine depletion in cancer cells and the cancer microenvironment could play a significant role in revolutionizing cancer treatment and cure through immunotherapy.